Abemaciclib becomes first CDK inhibitor to clinch single-agent approval for breast cancerFebruary 19, 2018Breast Cancer
Checkpoint inhibitors forge new treatment paradigm for metastatic bladder cancerFebruary 18, 2018Genitourinary Cancer
Concurrent ipilimumab and CMV colitis refractory to oral steroidsFebruary 18, 2018MelanomaPatient & Survivor Care
Recurrent head and neck cancer presenting as a large retroperitoneal massFebruary 18, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
Massive liver metastasis from colon adenocarcinoma causing cardiac tamponadeFebruary 18, 2018GastroenterologyPatient & Survivor Care
Cardiac pleomorphic sarcoma after placement of Dacron graftFebruary 18, 2018Sarcoma & GISTPatient & Survivor Care
Patient navigators’ personal experiences with cancer: does it have an impact on treatment?February 18, 2018Patient & Survivor Care
From angst to analytics: lessons learned from an oncology care model internal pilotFebruary 7, 2018Patient & Survivor Care
Clinical presentation, diagnosis, and management of typical and atypical bronchopulmonary carcinoidJanuary 10, 2018Lung Cancer
Cancer care in 2017: the promise of more cures with the challenges of an unstable health care systemDecember 15, 2017
Expanding treatment options for diverse neuroendocrine tumorsDecember 15, 2017GastroenterologyLung Cancer
Supportive medications and interventions received by prostate cancer survivors: results from the PiCTure studyDecember 15, 2017Genitourinary Cancer
Differences in psychosocial stressors between black and white cancer patientsDecember 15, 2017Patient & Survivor Care
